Latest:
Recent Progress in the Prostate Cancer Treatment Landscape
Key opinion leaders provide a broad perspective on recent shifts in the treatment landscape for prostate cancer.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Eileen M. O'Reilly, MD
Latest:
Dr. O'Reilly on Veliparib/Chemotherapy Triplet in Germline BRCA/PALB2+ Pancreatic Cancer
Eileen M. O’Reilly, MD, discusses the randomized phase II trial of gemcitabine and cisplatin versus gemcitabine and cisplatin and veliparib in patients with pancreas adenocarcinoma harboring a known germline BRCA or PALB2 mutation, which was presented at the 2020 Gastrointestinal Cancers Symposium.
Eileen M. O'Reilly, MD
Eileen M. O’Reilly, MD, is the Winthrop Rockefeller Endowed Chair of Medical Oncology and section head of hepatopancreaticobi at Memorial Sloan Kettering Cancer Center, as well as codirector of medical initiatives at the David M. Rubenstein Center for Pancreatic Cancer Research, in New York.
Latest:
Dr O’Reilly on the Potential of TTFields in Unresectable, Locally Advanced Pancreatic Cancer
Eileen M. O’Reilly, MD, discusses the potential of tumor treating fields for the treatment of patients with locally advanced pancreatic cancer.
Elaine Shum, MD
Elaine Shum, MD is an Assistant Professor of Medicine at NYU Perlmutter Cancer Center in New York.
Latest:
Dr Shum on Evolving First-Line Treatment Approaches for EGFR-Mutant NSCLC
Elaine Shum, MD, discusses questions that remain regarding the first-line treatment paradigm for patients with EGFR-mutant non–small cell lung cancer.
Eleanor M. Walker, MD
Latest:
Dr. Walker on the Use of Radiation Therapy in Patients With Breast Cancer
Eleanor M. Walker, MD, senior staff physician, division director, Breast Services in the Department of Radiation Oncology, Henry Ford Cancer Institute, discusses the use of radiation therapy in patients with breast cancer.